Cardiovascular Systems, Inc. Reports Fiscal 2021 Second-quarter Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/18/2026
- Tech stocks weigh on Wall Street as Iran stalemate lifts oil, yields
- Baidu slips as Q2 results miss estimates despite growth in AI cloud business
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Home Depot beats estimates, reaffirms fiscal 2026 guidance
- Citi says positioning risk is shifting from short squeezes to profit-taking
- Wall Street indexes slip as oil prices rise, retail results awaited
- Micron rises as White House presses Apple to avoid Chinese memory chips
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Trump threatens to bomb Oman over Iran stance
- U.S. EV market shows signs of bottoming out: Bernstein
Cardiovascular Systems (CSII) Tops Q2 EPS by 6c, Revenues Miss; Offers 3Q Revenue Guidance Below Consensus
February 3, 2021 4:43 PM ESTCardiovascular Systems (NASDAQ: CSII) reported Q2 EPS of $0.00, $0.06 better than the analyst estimate of ($0.06). Revenue for the quarter came in at $64.2 million versus the consensus estimate of $65.51 million.
Revenues of $64.2 million increased 6% sequentially compared to first quarterNet loss was $0.1 million, or $0.00 per basic and diluted shareManagement provides fiscal 2021 third quarter revenue guidance of $60 million to $65 millionReceives CE Mark for Diamondback 360® Coronary Orbital Atherectomy SystemSachin H.... More